Review




Structured Review

Cayman Chemical perhexiline (maleate)
( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or <t>Perhexiline.</t> Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.
Perhexiline (Maleate), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline (maleate)/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
perhexiline (maleate) - by Bioz Stars, 2026-02
90/100 stars

Images

1) Product Images from "Mitochondrial fatty acid oxidation regulates adult muscle stem cell function through modulating metabolic flux and protein acetylation"

Article Title: Mitochondrial fatty acid oxidation regulates adult muscle stem cell function through modulating metabolic flux and protein acetylation

Journal: The EMBO Journal

doi: 10.1038/s44318-025-00397-1

( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Perhexiline. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.
Figure Legend Snippet: ( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Perhexiline. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.

Techniques Used: Immunofluorescence, Control, Two Tailed Test, Cell Counting

( A ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 4–6 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For differentiation index, 50 μM vs. control, P = 0.0057; 100 μM vs. control, P = 0.0013. For fusion index, 50 μM vs. control, P = 0.0021; 100 μM vs. control, P = 0.00032. Scale bar, 500 μm (top); 100 μm (bottom). ( B ) Immunoblots showing relative levels of MF20 and Cpt2 in primary myoblasts treated with vehicle control or Etomoxir (50 µM). ( C ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Perhexiline (5 µM) and Oxfenicine (2.5 mM). Error bars represent mean ± s.e.m. with n = 3–6 replicates. * P < 0.05, ** P < 0.01; two tailed, unpaired Student’s t test. For differentiation index, Perhexiline vs. control, P = 0.0472; Oxfenicine vs. control, P = 0.012. For fusion index, Perhexiline vs. control, P = 0.0025; Oxfenicine vs. control, P = 0.01052. Scale bar, 200 μm (top); 100 μm (bottom).
Figure Legend Snippet: ( A ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 4–6 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For differentiation index, 50 μM vs. control, P = 0.0057; 100 μM vs. control, P = 0.0013. For fusion index, 50 μM vs. control, P = 0.0021; 100 μM vs. control, P = 0.00032. Scale bar, 500 μm (top); 100 μm (bottom). ( B ) Immunoblots showing relative levels of MF20 and Cpt2 in primary myoblasts treated with vehicle control or Etomoxir (50 µM). ( C ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Perhexiline (5 µM) and Oxfenicine (2.5 mM). Error bars represent mean ± s.e.m. with n = 3–6 replicates. * P < 0.05, ** P < 0.01; two tailed, unpaired Student’s t test. For differentiation index, Perhexiline vs. control, P = 0.0472; Oxfenicine vs. control, P = 0.012. For fusion index, Perhexiline vs. control, P = 0.0025; Oxfenicine vs. control, P = 0.01052. Scale bar, 200 μm (top); 100 μm (bottom).

Techniques Used: Immunofluorescence, Control, Two Tailed Test, Western Blot

Reagents and tools table
Figure Legend Snippet: Reagents and tools table

Techniques Used: Produced, Ex Vivo, In Vitro, Sequencing, Red Blood Cell Lysis, Modification, Saline, Blocking Assay, Plasmid Preparation, Protease Inhibitor, Reverse Transcription, Isolation, Bicinchoninic Acid Protein Assay, Western Blot, In Situ, Fluorescence, Detection Assay, TUNEL Assay, Software, Microscopy, Mass Spectrometry, Liquid Chromatography



Similar Products

93
MedChemExpress perhexiline maleate in vitro treatments
Perhexiline Maleate In Vitro Treatments, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline maleate in vitro treatments/product/MedChemExpress
Average 93 stars, based on 1 article reviews
perhexiline maleate in vitro treatments - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

91
Tocris perhexiline maleate
Perhexiline Maleate, supplied by Tocris, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline maleate/product/Tocris
Average 91 stars, based on 1 article reviews
perhexiline maleate - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

90
Cayman Chemical perhexiline (maleate)
( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or <t>Perhexiline.</t> Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.
Perhexiline (Maleate), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline (maleate)/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
perhexiline (maleate) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
MedChemExpress perhexiline maleate
( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or <t>Perhexiline.</t> Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.
Perhexiline Maleate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline maleate/product/MedChemExpress
Average 93 stars, based on 1 article reviews
perhexiline maleate - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Cayman Chemical perhexiline maleate salt
( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or <t>Perhexiline.</t> Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.
Perhexiline Maleate Salt, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perhexiline maleate salt/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
perhexiline maleate salt - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Perhexiline. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.

Journal: The EMBO Journal

Article Title: Mitochondrial fatty acid oxidation regulates adult muscle stem cell function through modulating metabolic flux and protein acetylation

doi: 10.1038/s44318-025-00397-1

Figure Lengend Snippet: ( A ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t test (10 μM vs. control, P = 0.2519; 50 μM vs. control, P = 0.0042; 100 μM vs. control, P = 0.0087; 200 μM vs. control, P = 2.42 × 10 −5 ). n.s. no significance. Scale bar, 50 μm. ( B ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Oxfenicine. Error bars represent mean ± s.e.m. with n = 3 replicates. * P < 0.05, *** P < 0.001; two tailed, unpaired Student’s t test. For Ki67 + /Pax7 + percentage, 2.5 mM vs. control, P = 0.13; 10 mM vs. control, P = 0.0187. For cell count (%), 2.5 mM vs. control, P = 0.00016; 10 mM vs. control, P = 7.97 × 10 −7 ; 2.5 mM vs. 10 mM, P = 0.00017; n.s. no significance. Scale bar, 50 μm. ( C ) Ki67 immunofluorescence (green) and quantification of percentages of Ki67 + primary myoblasts treated with vehicle control or Perhexiline. Error bars represent mean ± s.e.m. with n = 6–9 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For Ki67 + /Pax7 + percentage, 2.5 μM vs. control, P = 0.00049; 5 μM vs. control, P = 0.00231; For cell count (%), 2.5 μM vs. control, P = 0.00011; 5 μM vs. control, P = 7.43 × 10 −5 ; 2.5 μM vs. 5 μM, P = 0.0037. Scale bar, 50 μm.

Article Snippet: Perhexiline (maleate) , Cayman Chemical , Cat# 16982.

Techniques: Immunofluorescence, Control, Two Tailed Test, Cell Counting

( A ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 4–6 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For differentiation index, 50 μM vs. control, P = 0.0057; 100 μM vs. control, P = 0.0013. For fusion index, 50 μM vs. control, P = 0.0021; 100 μM vs. control, P = 0.00032. Scale bar, 500 μm (top); 100 μm (bottom). ( B ) Immunoblots showing relative levels of MF20 and Cpt2 in primary myoblasts treated with vehicle control or Etomoxir (50 µM). ( C ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Perhexiline (5 µM) and Oxfenicine (2.5 mM). Error bars represent mean ± s.e.m. with n = 3–6 replicates. * P < 0.05, ** P < 0.01; two tailed, unpaired Student’s t test. For differentiation index, Perhexiline vs. control, P = 0.0472; Oxfenicine vs. control, P = 0.012. For fusion index, Perhexiline vs. control, P = 0.0025; Oxfenicine vs. control, P = 0.01052. Scale bar, 200 μm (top); 100 μm (bottom).

Journal: The EMBO Journal

Article Title: Mitochondrial fatty acid oxidation regulates adult muscle stem cell function through modulating metabolic flux and protein acetylation

doi: 10.1038/s44318-025-00397-1

Figure Lengend Snippet: ( A ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Etomoxir. Error bars represent mean ± s.e.m. with n = 4–6 replicates. ** P < 0.01, *** P < 0.001; two tailed, unpaired Student’s t -test. For differentiation index, 50 μM vs. control, P = 0.0057; 100 μM vs. control, P = 0.0013. For fusion index, 50 μM vs. control, P = 0.0021; 100 μM vs. control, P = 0.00032. Scale bar, 500 μm (top); 100 μm (bottom). ( B ) Immunoblots showing relative levels of MF20 and Cpt2 in primary myoblasts treated with vehicle control or Etomoxir (50 µM). ( C ) Immunofluorescence of MyoG (red) and MF20 (green) and quantification of differentiation and fusion index in primary myoblasts treated with vehicle control or Perhexiline (5 µM) and Oxfenicine (2.5 mM). Error bars represent mean ± s.e.m. with n = 3–6 replicates. * P < 0.05, ** P < 0.01; two tailed, unpaired Student’s t test. For differentiation index, Perhexiline vs. control, P = 0.0472; Oxfenicine vs. control, P = 0.012. For fusion index, Perhexiline vs. control, P = 0.0025; Oxfenicine vs. control, P = 0.01052. Scale bar, 200 μm (top); 100 μm (bottom).

Article Snippet: Perhexiline (maleate) , Cayman Chemical , Cat# 16982.

Techniques: Immunofluorescence, Control, Two Tailed Test, Western Blot

Reagents and tools table

Journal: The EMBO Journal

Article Title: Mitochondrial fatty acid oxidation regulates adult muscle stem cell function through modulating metabolic flux and protein acetylation

doi: 10.1038/s44318-025-00397-1

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Perhexiline (maleate) , Cayman Chemical , Cat# 16982.

Techniques: Produced, Ex Vivo, In Vitro, Sequencing, Red Blood Cell Lysis, Modification, Saline, Blocking Assay, Plasmid Preparation, Protease Inhibitor, Reverse Transcription, Isolation, Bicinchoninic Acid Protein Assay, Western Blot, In Situ, Fluorescence, Detection Assay, TUNEL Assay, Software, Microscopy, Mass Spectrometry, Liquid Chromatography